Sun Pharmaceutical Industries had received tentative approval from the US health regulator for its generic clopidogrel tablets used for treating heart ailments. United States Food and Drug Administration (USFDA) have granted the company's subsidiary a tentative approval for its abbreviated new drug application (ANDA) for generic clopidogrel tablets USP.
The generic clopidogrel tablets USP in the strength of 75 mg are equivalents of Sanofi Aventis's Plavix tablets. Clopidogrel tablets USP have annual sale of about $6 billion in America. The tablets are indicated for the treatment of acute coronary syndrome, recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1845.90 |
| Dr. Reddys Lab | 1270.10 |
| Cipla | 1292.00 |
| Zydus Lifesciences | 930.75 |
| Lupin | 2246.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: